These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment.
    Author: Herukka SK, Hallikainen M, Soininen H, Pirttilä T.
    Journal: Neurology; 2005 Apr 12; 64(7):1294-7. PubMed ID: 15824371.
    Abstract:
    Baseline CSF amyloid beta-peptide-42 (Abeta42), tau, and phosphorylated tau (P-tau) levels from 46 control subjects and 78 patients with mild cognitive impairment (MCI) were measured. Twenty-three patients with MCI developed dementia during the study. Abnormal biomarkers were found early in the course of Alzheimer disease (AD). The most predictive assay for AD among the patients with MCI was the combination of Abeta42 and P-tau.
    [Abstract] [Full Text] [Related] [New Search]